Correspondingly, there was a considerable decrease in the expression of typical ECM components, including type I and III collagen, fibronectin, and elastin, in glycyrrhizin-treated keloid spheroids (*** p < 0.001, Figure 5d). The gene discussed is FN1; the disease is keloid.